Submitted: 06 November 2026 You are already at the latest version PD-1 is an inhibitory receptor on T cells that, when bound by PD-L1 or PD-L2, suppresses anti-tumor immunity. Tumors can exploit this pathway through overexpression of PD-L1, often driven by 9p24.1 chromosomal alterations.
Max Gordon
As seen in:
Wiley Online Library,
BMJ Open,
HemOnc Today,
Lexology,
Texas Medical Center,
Preprints.org
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Max
Contact Max, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack